Trifecta valve
Devicesurgical replacement of aortic valve
NCT Number: NCT01514162
To further evaluate the long term clinical safety and effectiveness of the Trifecta valve
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Abbott Northwestern Hospital Cardiac Surgical Associates, Minneapolis, Minnesota, United States
To further evaluate the long term clinical safety and effectiveness of the Trifecta valve in subjects who had a Trifecta valve implanted during the IDE study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
surgical replacement of aortic valve
Time frame: 5 years
Late patient years are calculated from 31 days post-implant to the date of the last follow-up visits (or contact) or adverse events.
Late Patient year calculation:[(Number of late adverse events/sum of late patient years) x 100]
Time frame: 5 years
The New York Heart Association (NYHA) functional classification system relates symptoms to everyday activities and the patient's quality of life.
Class I. Patients with cardiac disease but without resulting limitation of physical activity.
Class II. Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest.
Class III. Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest.
Class IV. Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome may be present even at rest.
The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, Mass: Little, Brown & Co; 1994:253-256.
Time frame: 5 years
Gradient is the pressure difference from one side of the valve to the other side of the valve. For this study pressure is measured in mmHg.
Mean gradient for each patient is the average of the pressure differences from one side of the valve to the other side of the valve.
Mean gradient for each valve size (19mm, 21mm, 23mm, 25mm, 27mm, 29mm)is the average of the mean gradient for each patient with that valve size.
Abbott Medical Devices
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07249424
Aortic Diseases, Cardiomyopathies
Konya, Turkey (Türkiye)
View Trial DetailsNCT07365488
Cardiovascular Diseases, Dyssomnias
Baghdad, Baghdad Governorate, Iraq
View Trial DetailsNCT04787757
Cardiovascular Diseases, Heart Diseases
Milan, MI, Italy
View Trial DetailsNCT05143671
Arterial Occlusive Diseases, Arteriosclerosis
Roma, Italy
View Trial Details